Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.by: , Kerby Shedden, Jeremy M G M Taylor, Steven A A Enkemann, Ming-Sound S Tsao, Timothy J J Yeatman, William L L Gerald, Steven Eschrich, Igor Jurisica, Thomas J J Giordano, David E E Misek, Andrew C C Chang, Chang Qi Q Zhu, Daniel Strumpf, Samir Hanash, Frances A A Shepherd, Keyue Ding, Lesley Seymour, Katsuhiko Naoki, Nathan Pennell, Barbara Weir, Roel Verhaak, Christine Ladd-Acosta, Todd Golub, Michael Gruidl, Anupama Sharma, Janos Szoke, Maureen Zakowski, Valerie Rusch, Mark Kris, Agnes Viale, Noriko Motoi, William Travis, Barbara Conley, Venkatraman E E Seshan, Matthew Meyerson, Rork Kuick, Kevin K K Dobbin, Tracy Lively, James W W Jacobson, David G G Beer, Kerby Shedden, Jeremy M G M Taylor, Steven A A Enkemann, Ming-Sound S Tsao, Timothy J J Yeatman, William L L Gerald, Steven Eschrich, Igor Jurisica, Thomas J J Giordano, David E E Misek, Andrew C C Chang, Chang Qi Q Zhu, Daniel Strumpf, Samir Hanash, Frances A A Shepherd, Keyue Ding, Lesley Seymour, Katsuhiko Naoki, Nathan Pennell, Barbara Weir, Roel Verhaak, Christine Ladd-Acosta, Todd Golub, Michael Gruidl, Anupama Sharma, Janos Szoke, Maureen Zakowski, Valerie Rusch, Mark Kris, Agnes Viale, Noriko Motoi, William Travis, Barbara Conley, Venkatraman E E Seshan, Matthew Meyerson, Rork Kuick, Kevin K K Dobbin, Tracy Lively, James W W Jacobson, David G G Beer
Nature medicine (20 July 2008)
|
Reviews
[Write a review of this article]
There are no reviews of this article
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
AbstractAlthough prognostic gene expression signatures for survival in early-stage lung cancer have been proposed, for clinical application, it is critical to establish their performance across different subject populations and in different laboratories. Here we report a large, training-testing, multi-site, blinded validation study to characterize the performance of several prognostic models based on gene expression for 442 lung adenocarcinomas. The hypotheses proposed examined whether microarray measurements of gene expression either alone or combined with basic clinical covariates (stage, age, sex) could be used to predict overall survival in lung cancer subjects. Several models examined produced risk scores that substantially correlated with actual subject outcome. Most methods performed better with clinical data, supporting the combined use of clinical and molecular information when building prognostic models for early-stage lung cancer. This study also provides the largest available set of microarray data with extensive pathological and clinical annotation for lung adenocarcinomas.
BibTeX record
RIS record